当前位置:
X-MOL 学术
›
J. Clin. Endocrinol. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. A meta-analysis
The Journal of Clinical Endocrinology & Metabolism ( IF 5.8 ) Pub Date : 2021-08-12 , DOI: 10.1210/clinem/dgab564 Luca Giovanella 1, 2 , Maria Luisa Garo 3 , Luca Ceriani 1, 4 , Gaetano Paone 1 , Alfredo Campenni' 5 , Federica D'Aurizio 6
The Journal of Clinical Endocrinology & Metabolism ( IF 5.8 ) Pub Date : 2021-08-12 , DOI: 10.1210/clinem/dgab564 Luca Giovanella 1, 2 , Maria Luisa Garo 3 , Luca Ceriani 1, 4 , Gaetano Paone 1 , Alfredo Campenni' 5 , Federica D'Aurizio 6
Affiliation
This study aimed to determine the procalcitonin (ProCT) diagnostic accuracy in prediction and treatment monitoring of medullary thyroid carcinoma (MTC).
中文翻译:
降钙素原作为甲状腺髓样癌的替代肿瘤标志物。荟萃分析
本研究旨在确定降钙素原(ProCT)在甲状腺髓样癌(MTC)的预测和治疗监测中的诊断准确性。
更新日期:2021-08-12
中文翻译:
降钙素原作为甲状腺髓样癌的替代肿瘤标志物。荟萃分析
本研究旨在确定降钙素原(ProCT)在甲状腺髓样癌(MTC)的预测和治疗监测中的诊断准确性。